Claims for Patent: 10,478,478

✉ Email this page to a colleague

Summary for Patent: 10,478,478

Title:	Treatment of Raynaud\'s phenomenon using botulinum toxin type B
Abstract:	An effective amount of botulinum toxin type B is administered to a subject in need thereof for treating Raynaud\'s phenomenon. Botulinum toxin type B may be in a form of an injection, and may be locally administered to a disease affected site, in a dose of 200 to 400 units per disease affected site.
Inventor(s):	Motegi; Sei-ichiro (Gunma, JP)
Assignee:	NATIONAL UNIVERSITY CORPORATION GUNMA UNIVERSITY (Gunma, JP)
Application Number:	15/941,089
Patent Claims:	1. A method of treating Raynaud's phenomenon, comprising administering a therapeutically effective amount of botulinum toxin type B to a subject in need thereof, wherein said botulinum toxin type B is injected to sites between fingers and at the external sides of metacarpophalangeal joints of the first and fifth fingers of the subject. 2. The method according to claim 1, wherein said botulinum toxin type B is injected to the subject at a dose of 200 to 400 units per one injection.

Details for Patent 10,478,478

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Solstice Neurosciences, Llc	MYOBLOC	rimabotulinumtoxinb	Injection	103846	December 08, 2000	⤷ Subscribe	2037-03-31
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.